Becaplermin (Regranex) for diabetic foot ulcers

被引：0
|
作者：
Jarvis, Courtney I. [1 ]
机构：
[1] Massachusetts Coll Pharm & Hlth Sci, Worcester, MA USA
来源：
AMERICAN FAMILY PHYSICIAN | 2008年 / 78卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：255 / 256
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of graftskin (ApliGraf) and becaplermin (Regranex) in diabetic neuropathic foot ulcers
    Park, J
    Hay, JW
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 332 - 332
  • [2] Becaplermin gel in the treatment of diabetic neuropathic foot ulcers
    Papanas, Nikolaos
    Maltezos, Efstratios
    [J]. CLINICAL INTERVENTIONS IN AGING, 2008, 3 (02) : 233 - 240
  • [3] Safety and efficacy of Becaplermin gel in the treatment of diabetic foot ulcers
    Blume, Peter
    Bowlby, Melinda
    Schmidt, Brian M.
    Donegan, Ryan
    [J]. CHRONIC WOUND CARE MANAGEMENT AND RESEARCH, 2014, 1 : 11 - 14
  • [4] Regranex - Platelet growth factor for treating diabetic ulcers of the leg and foot
    不详
    [J]. FORMULARY, 1998, 33 (03) : 176 - 177
  • [5] A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers
    Fang, Robert C.
    Galiano, Robert D.
    [J]. BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 1 - 12
  • [6] Benefit-Risk Assessment of Becaplermin in the Treatment of Diabetic Foot Ulcers
    DrNikolaos Papanas
    Efstratios Maltezos
    [J]. Drug Safety, 2010, 33 : 455 - 461
  • [7] Benefit-Risk Assessment of Becaplermin in the Treatment of Diabetic Foot Ulcers
    Papanas, Nikolaos
    Maltezos, Efstratios
    [J]. DRUG SAFETY, 2010, 33 (06) : 455 - 461
  • [8] Cost effectiveness of becaplermin in the treatment of diabetic foot ulcers in four European countries
    Ghatnekar, O
    Persson, U
    Willis, M
    Ödegaard, K
    [J]. PHARMACOECONOMICS, 2001, 19 (07) : 767 - 778
  • [9] Cost-effectiveness of becaplermin gel on wound healing of diabetic foot ulcers
    Gilligan, Adrienne M.
    Waycaster, Curtis R.
    Motley, Travis A.
    [J]. WOUND REPAIR AND REGENERATION, 2015, 23 (03) : 353 - 360
  • [10] Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries
    Ola Ghatnekar
    Ulf Persson
    Michael Willis
    Knut Ödegaard
    [J]. PharmacoEconomics, 2001, 19 : 767 - 778
12345